
Ferritin: More Than Iron—A Diagnostic Power Tool
June 24, 2025/by Nidhi Reva
“Not All in Her Head”: Callie’s Story of Seizures, Strength, and Starting Over
June 19, 2025/by Nidhi Reva
An Important Reminder From Nurse Nan: Save Your Tick
June 17, 2025/by Nan Kinder, RN
“I Think I’m Losing My Mind”: When Treating Tick-Borne Illness Feels Worse Before It Gets Better
June 12, 2025/by Nidhi Reva
A Patient’s Story: From Pushing Herself to Be Stronger—To Acceptance
June 12, 2025/by Nidhi Reva
Long COVID Webinar and Q&A
June 3, 2025/by Kaplan Center
Good Morning Washington Visits the Kaplan Center! Part 2
June 2, 2025/by Kaplan Center
Good Morning Washington Visits The Kaplan Center! Part 1
May 13, 2025/by Kaplan Center
Which Respiratory Infection Do You Have?
December 10, 2024/by Kaplan Center
Eating “Right” But Feeling Wrong? The Problem with One-Size-Fits-All Diets and Blood Sugar
December 4, 2024/by Kaplan Center
Nutrition Tips for Thyroid Health
November 21, 2024/by Kaplan Center
4 Ways to Practice Gratitude During the Holidays
November 21, 2024/by Gary Kaplan, DO
Out of the Fog: Strategies to Prevent Brain Fog and Sharpen Cognitive Function
November 19, 2024/by Kaplan Center
Employee of the Quarter: Marlene Ekwede
October 28, 2024/by Kaplan Center
Stop Eating These Foods And Clear Up Your Brain!
October 28, 2024/by Gary Kaplan, DO
8 Tips To Help You Manage Your Medications
October 21, 2024/by Gary Kaplan, DO
Preventing & Treating Osteoporosis with Yoga, Resistance Training, Diet, & Medications
October 14, 2024/by Lisa Lilienfield, MD
The Role of Functional Medicine in Managing Chronic Inflammation
October 9, 2024/by Kaplan Center
Living Longer, Living Better: Advanced Diagnostics and Unique Treatments for Longevity
October 4, 2024/by Lisa Lilienfield, MD
8 Steps to a Healthier Gut
October 3, 2024/by Kaplan CenterAre you looking to improve your overall wellness?
Personalized care you can trust.
Our integrative, non-surgical treatment approach is highly successful in maintaining wellness and also treating chronic pain and illness. For more than 30 years, we have delivered superior, cutting-edge health care in the Washington, DC area.
QuickLinks
Contact Information
Tel: 703-532-4892
Fax: 703-237-3105
6829 Elm Street, Suite 300
McLean, Virginia 22101
Map It
Hours of Operation
Mon – Thu : 8 am – 5 pm, ET
Fri : 8 am – 12 pm, ET
New Migraine Drug Approved by U.S. Food & Drug Administration
/in News, Treatments/by Kaplan CenterA new medication was recently approved by the FDA for migraine sufferers. According to the FDA, Aimovig is the first in a new class of drugs “that work by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.”
An article published in Science News explains what is known – and what is still unknown – about this new medication. You can read the summary below or by clicking here.
[gview file=”//kaplanclinic.com/pdfs/What_You_Need_To_Know_About_Aimovig_Science_News_6.5.18.pdf”]
Dr. Peter Diamandis on Technology, Longevity, and Great Ideas
/in News, Wellness/by Gary Kaplan, DOPeter Diamandis, MD, PhD, author of the books Abundance and Bold, founder of XPRIZE Foundation, and co-founder of the companies Human Longevity and Planetary Resources, gave a keynote address at the Vatican that focused on longevity and innovation in the field of regenerative medicine.
Dr. Diamandis’ remarks were both thought provoking and inspiring and I thought it was a wonderful piece to share with you. I hope you enjoy it as much as I did!
– Dr. Kaplan
New Breast Cancer Study Supports A More Gentle Approach to Treatment
/in News/by Lisa Lilienfield, MDA study published in the New England Journal of Medicine this month is good news for women who want more personalized care for treatment of breast cancer.
10,000 women were followed over 9 years. These women had early stage, receptive to hormones and negative to a receptor called HER2, all characteristics of the most common type of breast cancer. They then had genetic testing and given a score that predicts risk of breast cancer recurrence after surgery. Low scorers can be treated with hormone therapy and high scorers do better with chemotherapy and hormone therapy. The middle scorers were divided into 2 groups – chemo plus hormones or hormones only. After 9 years, the cancer-free rate for both of the groups that scored in the middle after genetic testing were similar, 83-84%.
Side effects from chemotherapy can be very disruptive, so this is study is very exciting for women desiring a more gentle approach.
Lisa Lilienfield, MD